G Medical Innovations Holdings Ltd
GMVDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$51
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $51.00 |
|---|---|
| Enterprise Value | $1.80 Million |
| Earnings per Share | $-34.17 |
| Beta | -1.12 |
| Outstanding Shares | 514,455 |
Return
| Return on Equity | 95.31% |
|---|---|
| Return on Assets | -145.24% |
| Return on Invested Capital | 63.62% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 0.3 |
| Enterprise Value to EBIT | -0.66 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.16 |
| Debt to Equity | -0.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About G Medical Innovations Holdings Limited
84 employees
CEO: Yacov Geva
G Medical Innovations Holdings Ltd operates as an emerging healthcare enterprise, focused on pioneering advanced mobile health and remote medical solutions across the United States, China, and Israel. Its product line includes Prizma, an...